836 related articles for article (PubMed ID: 30271077)
1. Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease.
Torres JL; Novo-Veleiro I; Manzanedo L; Alvela-Suárez L; Macías R; Laso FJ; Marcos M
World J Gastroenterol; 2018 Sep; 24(36):4104-4118. PubMed ID: 30271077
[TBL] [Abstract][Full Text] [Related]
2. The functional role of microRNAs in alcoholic liver injury.
McDaniel K; Herrera L; Zhou T; Francis H; Han Y; Levine P; Lin E; Glaser S; Alpini G; Meng F
J Cell Mol Med; 2014 Feb; 18(2):197-207. PubMed ID: 24400890
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs in alcoholic liver disease: Recent advances and future applications.
Xu T; Li L; Hu HQ; Meng XM; Huang C; Zhang L; Qin J; Li J
J Cell Physiol; 2018 Jan; 234(1):382-394. PubMed ID: 30076710
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs in non-alcoholic fatty liver disease: Progress and perspectives.
Hochreuter MY; Dall M; Treebak JT; Barrès R
Mol Metab; 2022 Nov; 65():101581. PubMed ID: 36028120
[TBL] [Abstract][Full Text] [Related]
5. Intracellular and extracellular miRNome deregulation in cellular models of NAFLD or NASH: Clinical implications.
Di Mauro S; Ragusa M; Urbano F; Filippello A; Di Pino A; Scamporrino A; Pulvirenti A; Ferro A; Rabuazzo AM; Purrello M; Purrello F; Piro S
Nutr Metab Cardiovasc Dis; 2016 Dec; 26(12):1129-1139. PubMed ID: 27756518
[TBL] [Abstract][Full Text] [Related]
6. Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage.
Neuman MG; French SW; Zakhari S; Malnick S; Seitz HK; Cohen LB; Salaspuro M; Voinea-Griffin A; Barasch A; Kirpich IA; Thomes PG; Schrum LW; Donohue TM; Kharbanda KK; Cruz M; Opris M
Exp Mol Pathol; 2017 Feb; 102(1):162-180. PubMed ID: 28077318
[TBL] [Abstract][Full Text] [Related]
7. A Series of microRNA in the Chromosome 14q32.2 Maternally Imprinted Region Related to Progression of Non-Alcoholic Fatty Liver Disease in a Mouse Model.
Okamoto K; Koda M; Okamoto T; Onoyama T; Miyoshi K; Kishina M; Kato J; Tokunaga S; Sugihara TA; Hara Y; Hino K; Murawaki Y
PLoS One; 2016; 11(5):e0154676. PubMed ID: 27135827
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-194 inhibition improves dietary-induced non-alcoholic fatty liver disease in mice through targeting on FXR.
Nie H; Song C; Wang D; Cui S; Ren T; Cao Z; Liu Q; Chen Z; Chen X; Zhou Y
Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3087-3094. PubMed ID: 28951211
[TBL] [Abstract][Full Text] [Related]
9. Dysregulation of miR-21-associated miRNA regulatory networks by chronic ethanol consumption impairs liver regeneration.
Parrish A; Srivastava A; Juskeviciute E; Hoek JB; Vadigepalli R
Physiol Genomics; 2021 Dec; 53(12):546-555. PubMed ID: 34796728
[TBL] [Abstract][Full Text] [Related]
10. 'Micro-managers' of hepatic lipid metabolism and NAFLD.
Liu W; Cao H; Yan J; Huang R; Ying H
Wiley Interdiscip Rev RNA; 2015; 6(5):581-93. PubMed ID: 26198708
[TBL] [Abstract][Full Text] [Related]
11. miRNAs in non-alcoholic fatty liver disease.
He Z; Hu C; Jia W
Front Med; 2016 Dec; 10(4):389-396. PubMed ID: 27680976
[TBL] [Abstract][Full Text] [Related]
12. Integrative microRNA profiling in alcoholic hepatitis reveals a role for microRNA-182 in liver injury and inflammation.
Blaya D; Coll M; Rodrigo-Torres D; Vila-Casadesús M; Altamirano J; Llopis M; Graupera I; Perea L; Aguilar-Bravo B; Díaz A; Banales JM; Clària J; Lozano JJ; Bataller R; Caballería J; Ginès P; Sancho-Bru P
Gut; 2016 Sep; 65(9):1535-45. PubMed ID: 27196584
[TBL] [Abstract][Full Text] [Related]
13. miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease.
Castro RE; Ferreira DM; Afonso MB; Borralho PM; Machado MV; Cortez-Pinto H; Rodrigues CM
J Hepatol; 2013 Jan; 58(1):119-25. PubMed ID: 22902550
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic regulation of miR-34a expression in alcoholic liver injury.
Meng F; Glaser SS; Francis H; Yang F; Han Y; Stokes A; Staloch D; McCarra J; Liu J; Venter J; Zhao H; Liu X; Francis T; Swendsen S; Liu CG; Tsukamoto H; Alpini G
Am J Pathol; 2012 Sep; 181(3):804-17. PubMed ID: 22841474
[TBL] [Abstract][Full Text] [Related]
15. miRNAs in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Liu CH; Ampuero J; Gil-Gómez A; Montero-Vallejo R; Rojas Á; Muñoz-Hernández R; Gallego-Durán R; Romero-Gómez M
J Hepatol; 2018 Dec; 69(6):1335-1348. PubMed ID: 30142428
[TBL] [Abstract][Full Text] [Related]
16. Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis.
Pirola CJ; Fernández Gianotti T; Castaño GO; Mallardi P; San Martino J; Mora Gonzalez Lopez Ledesma M; Flichman D; Mirshahi F; Sanyal AJ; Sookoian S
Gut; 2015 May; 64(5):800-12. PubMed ID: 24973316
[TBL] [Abstract][Full Text] [Related]
17. High-throughput sequencing reveals altered expression of hepatic microRNAs in nonalcoholic fatty liver disease-related fibrosis.
Leti F; Malenica I; Doshi M; Courtright A; Van Keuren-Jensen K; Legendre C; Still CD; Gerhard GS; DiStefano JK
Transl Res; 2015 Sep; 166(3):304-14. PubMed ID: 26001595
[TBL] [Abstract][Full Text] [Related]
18. Molecular regulation of miRNAs and potential biomarkers in the progression of hepatic steatosis to NASH.
Wang Y; Liu Z; Zou W; Hong H; Fang H; Tong W
Biomark Med; 2015; 9(11):1189-200. PubMed ID: 26506944
[TBL] [Abstract][Full Text] [Related]
19. Fish Oil Feeding Modulates the Expression of Hepatic MicroRNAs in a Western-Style Diet-Induced Nonalcoholic Fatty Liver Disease Rat Model.
Wang H; Shao Y; Yuan F; Feng H; Li N; Zhang H; Wu C; Liu Z
Biomed Res Int; 2017; 2017():2503847. PubMed ID: 28691019
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs as controlled systems and controllers in non-alcoholic fatty liver disease.
Panera N; Gnani D; Crudele A; Ceccarelli S; Nobili V; Alisi A
World J Gastroenterol; 2014 Nov; 20(41):15079-86. PubMed ID: 25386056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
